Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06788977 · ClinicalTrials.gov registry record
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
A clinical trial of Depression and Anxiety, sponsored by Cefaly Technology.
- Recruiting
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT06788977: Recruiting study of Depression and Anxiety, sponsored by Cefaly Technology.
NCT06788977 is a study of Depression and Anxiety that is actively recruiting participants, run by Cefaly Technology. The registered enrollment target is 550 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06788977, a study of Depression and Anxiety, is actively recruiting participants, sponsored by Cefaly Technology.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not need to use external trigeminal nerve stimulation or any other form of migraine treatment to participate in the registry. The main question it aims to answer is: Is external trigeminal nerve stimulation a safe and effective option for migraine treatment during and after pregnancy? There are no required changes in migraine treatment to participate in this registry. Participants may or may not use external trigeminal nerve stimulation or any other treatment they currently use and may still participate in the registry. There are no clinic or research visits, as the registry is entirely online. Participants will be asked to complete up to six 15- 20-minute surveys over a time period of up to 12 months.
Conditions Studied
Interventions
- DEVICE external Trigeminal Nerve Stimulation
Study Locations (1)
Connecticut
- https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceLanguage=true - Darien
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2024-11-25 |
| Est. Completion | 2030-12 |
What NCT06788977 shows while recruiting
NCT06788977 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 679 other Depression trials with a reported enrollment target (30% lower).
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which external Trigeminal Nerve Stimulation is the first listed.
NCT06788977 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06788977 about?
NCT06788977 is a clinical study titled "External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy". This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not need to use external trigeminal nerve stimulation or any other form of migraine treatment to participate in the registry. ...
What is the current status of trial NCT06788977?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2024-11-25. Estimated completion is 2030-12.
What conditions does trial NCT06788977 study?
This clinical trial studies the following conditions: Depression, Anxiety, Pregnancy, Migraine, Headache.
What interventions are being tested in trial NCT06788977?
The interventions under investigation include: external Trigeminal Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06788977?
This trial is sponsored by Cefaly Technology, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06788977 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06788977's enrollment target sits among peer trials
550 72nd of 679 higher than 608 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy